Effects of metformin on learning and memory functions of young and aged rats


Creative Commons License

Barış Ö., Göçmez S. S., Komsuoğlu Çelikyurt F. İ., Utkan T.

12 th International Congress on Psychopharmacology and 8th International Symposium on Child and Adolescent Psychopharmacology, Antalya, Türkiye, 17 - 20 Kasım 2021, ss.26-29

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Basıldığı Şehir: Antalya
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.26-29
  • Kocaeli Üniversitesi Adresli: Evet

Özet

ICP 2021 Outstanding Research Award Nominees Brief Reports

0369 - Effects of metformin on learning and memory functions of young and aged rats

Ozgur Baris1-2, Semil Selcen Gocmez1, Ipek Komsuoglu Celikyurt1, Tijen Utkan1

1: Kocaeli University Faculty of Medicine, Department of Pharmacology, Kocaeli, Turkey., 2: Kocaeli University Faculty of Medicine, Department of Cardiovascular Surgery, Kocaeli, Turkey

BRIEF REPORT
OBJECTIVE: 
Aging is a multifactorial and progressive phenomenon, exclusively leading to loss of cellular, molecular and physiological functionality. It is well established that overproduction of free radicals such as reactive oxygen species (ROS) leads to oxidative stress which results in senescence and aging-related disorders. Moreover, the brain neurons are more susceptible to oxidative stress due to the presence of high lipid content and higher oxygen consumption.
The aim of this study was to investigate the effects of Metformin (Met), an antidiabetic biguanide, on learning and memory functions of young and aged rats using different behavioral tasks and combining with the PCR gene expression method as well as additional histological evidence, we were able to achieve a very unique result.

METHODS: Wistar-Albino male rats were separated into four groups: young mice (<12months-old), young mice +metformin, aged mice (24 months old), aged mice+ metformin. Metformin (100mg/kg) was supplemented into drinking water for 8 weeks. Morris water maze (MWM) and passive avoidance (PA) tests were used to determine learning and memory functions. Locomotor activity (locomotor activity cabinet system) was measured with a computerized system.

Locomotor activity test
Because old age and compounds altering locomotor activity may give false-positive/negative effects in behavioral tests, an additional test was carried out with the specific aim of monitoring motor activity. The spontaneous locomotor activity of the animals was assessed by monitoring their activity in a locomotor activity cage. Locomotor activity was mea
sured with a computerized system (40×40×35 cm box; May Commat, Ankara, Turkey). Total number of movements was measured for a 5-min period before the behavioral tests and is expressed as the sum of stereotypic, ambulatory, and vertical activity. In this study, the 24-month-old naturally aged rats were chosen, which do not have impaired locomotor activity or any neurological deficit, in order avoid false-positive/negative effects in behavioral tests.

Passive avoidance test
In this type of avoidance learning test, the animals were refraining from making measured response. A step-down variant passive avoidance apparatus was used (Ugo Basile model 7551, Italy). The app
aratus (measuring 22×21×22 cm) consisted of 2 compartments: a light and dark compartment separated by a guillotine door. On Day 1 (training trial), the rats were placed individually into light compartment and allowed to explore the boxes to become aware of environment.
1. Pre-acquisition trial: After 30 s, the door between the 2 boxes was opened, and animal moved into dark compartment freely.

page26image3727612768 page26image3727613056

2. The acquisition (training) trial was conducted 15 min after pre-acquisition trial. Rats were placed in light compartment, after 30-s adaptation period, door between the compartments were opened. Having completely entered dark compartment, door was automatically closed, and an electric foot-shock (0.5 mA) of 3-s duration was delivered to animal via grid floor. The time taken to reenter dark compartment was recorded (training latency). Any animal failing to cross from the light to dark compartment within 300 s was discarded from the experiment. Animals were then removed from dark compartment and returned to their home cages. Between each training session, both chamber compartments were cleaned to remove any confounding olfactory cues.

3. Retention trial: Recall of inhibitory stimulus was evaluated at 24-h post-training by returning animals to light compartment and recording their latency to enter dark compartment (4 paws in). No foot-shock was applied in this trial. If animal did not enter dark compartment within 300-s, it was returned to its cage and a maximum latency of 300-s was recorded. This latency served as a measure of retention performance of step- down avoidance responses (retention latency).

Morris water maze test
The Morris water maze consisted of a circular pool (150-cm di
ameter) was filled with water (25°C) and rendered opaque by addition of small white pieces of plastic. The pool was located in a dimly lit and soundproof test room with a camera and the experimenter. The maze was divided

page26image3726964272

into 4 quadrants. Three equally-spaced points around the edge of pool were used as release positions. Order of release positions was varied systematically throughout the experiment. An escape platform (6-cm in diameter and 12-cm high) was located in 1 quadrant, 1 cm above water surface during familiarization session and 1 cm below water surface during other sessions. Video tracking was conducted with a video camera (Sony Dcr-Hc40e) focused on full diameter of pool. The rats were trained in Morris water maze during 5 daily sessions (familiarization session, S1, S2, S3, and S4). The 5 sessions were performed on consecutive days between 9:00 and 12:00. During acquisition phase of experiments, each rat participated in 3 trials per day. For each daily trial, the rat was taken from home cage and placed into the water maze at 1 of 3 randomly

26

ICP 2021 Outstanding Research Award Nominees Brief Reports

determined locations with its head facing the center of water maze. A trial was started when rat was released from 1 of 3 randomly chosen start positions. After rat found and climbed onto platform, trial was stopped and escape latency was recorded. Maximum trial length was 60 s. If rat had not climbed onto platform within 60 s, the experimenter guided rat by hand to platform and an escape latency of 60 s was recorded. Inter- trial time was 60 s. During this time, rat was kept on escape platform before starting next trial. Rat was then placed in pool again, but at a different location, and next trial began upon its release. Normally, escape latency declines during acquisition as animal learns the location of hidden platform. At the end of third trial, rat was returned to its cage. Twenty-four hours after last acquisition session, a ‘probe trial’ was used

to assess rats’ spatial retention of location of hidden platform. During this trial, platform was removed from the maze, and each rat was allowed to search pool for 60 s before being removed. During this trial, animals should spend more time swimming in quadrant that previously contained the hidden platform than in other 3 quadrants.

After these tests, according to the guidelines of animal ethics committees, the hippocampus and the cortex of brain tissues was excised after the rats were sacrificed. The effect of senescence related inflammation on the tissues in aging rats was evaluated by PCR gene expression analysis. Histological study was performed for cortex and hippocampus tissues.

Statistics
All results are expressed as the mean ±S.E. Acquisition (1–4 days) latency scores in MWM test were measured by 2-way analysis of variance (ANOVA), following post hoc Bonferroni test. Scores of time spent in escape platform’s quadrant in MWM test, first day and retention latencies in PA test, total locomotor activity, and foot shock sensitivity scores were measured by 1-way ANOVA. Criteria for statistical significance was P<0.05. In PCR gene expression analyses, One way ANOVA, Post hoc / Tukey HSD were used and Kruskal Wallis analysis of variance was performed

for data that did not fit the normal distribution.

RESULTSIn MWM test, there’s a significant increase in acquisition latency (1-4 days) of 24-month-old rats. In acquisition session of MWM test, in day 1, there’s a significant difference between aged vs young rats. In day 2, there’s a significant difference between aged vs young rats and aged vs (young +met) group. In day 3, there’s a significant difference between aged vs young rats; aged vs (young +met) group and also (aged+met) group vs aged rats. In day 4, there’s a significant difference between (1) aged vs young rats and (2) aged vs (young+Met) and (3) (aged +Met) vs aged rats.

In probe trial of MWM test, there’s a significant difference between young vs aged rats. There’s a significant difference between (young+Met) vs aged rats and there’s a significant difference between aged vs (aged+met) group. In probe trial of MWM test, there’s a significant reduction in “time spent in the escape platform’s quadrant” in aged rats compared to young rats. Metformin treatment reversed reduction of “time spent in escape platform’s quadrant” of aged rats.

In PA test, there was no significant difference in 1st-day latency of rats in all groups. There’s a significant difference between young vs aged rats and there’s a significant difference between aged vs (aged+Met) group. The locomotor activity of rats was not affected.

A regular cerebral cortex was seen with neurons of normal morphology in the young control and young metformin groups. Degenerated neurons, intercellular and perivascular edema were observed in the aged control group. Regenerated neurons were observed with decreased edema in the aged metformin group. Hippocampus (CA2) with regular morphology was observed in the young control and young metformin groups. Degenerated neurons and severe pericellular and perivascular edema were observed in the aged control group, whereas neurons in the aged metformin group showed regeneration close to normal morphology.

By PCR gene expression analyses there was very significant results in all metformin groups p<0,001; Ki67 & NF- B & TNF- ➔ hippocampus and cortex

page27image3764506112 page27image3764506400

PDGFR- β & i-NOShippocampus TGF- & IL-6cortex

DISCUSSION: This study demonstrates that chronic metformin treatment affects learning and memory performance in different learning and memory tasks in aged animals. Memory function may be defined as the ability to acquire, process, store, and retrieve information. We investigated the effects of long-term administration of metformin in passive avoidance and Morris water maze test, finding that metformin improved spatial and emotional learning and memory in distinct behavioral tasks involving different brain structures including hippocampus and amygdala.

In our study, we used metformin which beyond its impact on glycemic control, it may have pleotropic effects targeting multiple age-related mechanisms. Previous studies have found that metformin decreases inflammatory markers, NF-κB, ROS and mTOR pathways, thus decreasing DNA damage. Our findings suggest that aging itself, negatively affects spatial and emotional memory functions in rats. Metformin administration might have an affirmative effect on age-related learning and memory dysfunctions. In response to age-related increased inflammatory and

oxidative stress, the neuroprotective effects seen in metformin groups correlate with learning and memory functions. The statistically significant decrease in inflammatory cytokine levels in hippocampus and cortex tissues with metformin and the increase in the levels of proliferation markers with cell-protective properties support the neuroprotective effects of metformin, and these results are consistent with histological findings.

27

References

Latency (s) to find the platform of Young, Young+Met, Aged, Aged+Met groups in MWM test.

25

20

15

10

5

0

**

Ag e d

#

Ag e d + M e t

ICP 2021 Outstanding Research Award Nominees Brief Reports

1.Valencia WM, Palacio A, Tamariz L, Florez H. Metformin and ageing: improving ageing outcomes beyond glycemic control. Diabetologia. 2017 Sep;60(9):1630-1638. doi: 10.1007/s00125-017-4349-5. Epub 2017 Aug 2.
2. Komsuoglu Celikyurt I et al. Exenatide Treatment Exerts Anxiolytic- and Antidepressant-Like Effects and Reverses Neuropathy in a Mouse Model of Type-2 Diabetes. Med Sci Monit Basic Res. 2014; 20: 112
117. Published online 2014 Jul 30. doi: 10.12659/MSMBR.891168.

3. Fatemi I, Khaluoi A, Kaeidi A, Shamsizadeh A, Heydari S, Allahtavakoli MA. Protective effect of metformin on D-galactose-induced aging model in mice. Iran J Basic Med Sci. 2018 Jan;21(1):19-25. doi: 10.22038/IJBMS.2017.24331.6071.
4. Bang E, Lee B, Park JO, Jang Y, Kim A, Kim S, Shin HS. The Improving Effect of HL271, a chemical derivative of metformin, a popular drug for type II diabetes mellitus, on aging-induced cognitive decline. Exp Neurobiol 2018 Feb;27(1):45-56. doi: 10.5607/en.2018.27.1.45. Epub 2018 Feb 12.

5. Zhang J, Lin Y, Dai X, Fang W, Wu X, Chen X. Metformin treatment improves the spatial memory of aged mice in an APOE genotype-dependent manner. FASEB J. 2019 Jun;33(6):7748-7757. doi: 10.1096/fj.201802718R. Epub 2019 Mar 20.

60

40

20

0

***

Young Young+Met Aged Aged+Met

****

#

page28image3737021584

****

##

page28image3737054720 page28image3737055136 page28image3737055424page28image3737018096 page28image3737018304

Day1 Day2 Day3 Day4

page28image3736186736 page28image3736187088 page28image3736187376 page28image3736188224 page28image3736188416 page28image3736188624 page28image3736189824 page28image3736190416 page28image3736190704page28image3736191680

28

Y o u n g

Y o u n g + M e t

Time spent in the escape platform quadrants of Young, Young+Met, Aged, Aged+Met groups in MWM test

Tim e spend in escape platform 's quadrant (sec)

Latency (1-4 days)

50 40 30 20 10

0

ICP 2021 Outstanding Research Award Nominees Brief Reports

page29image3736441776 page29image3736442064 page29image3736480480 page29image3736480768 page29image3736457488 page29image3736462576 page29image3736471712 page29image3736472000 page29image3736472208page29image3651894160

Y o u n g

Y o u n g + M e t

Ag e d

Ag e d + M e t

#

Ag e d + M e t

First day latency of Young, Young+Met, Aged, Aged+Met groups in the PA test

page29image3651913024

300

200

100

0

***

Ag e d

page29image3651918368 page29image3651918912 page29image3651919104 page29image3651919392 page29image3651920176 page29image3651920464 page29image3651920672 page29image3651921648 page29image3651913216page29image3651923392

Y o u n g

Y o u n g + M e t

Retention latency of Young, Young+Met, Aged, Aged+Met groups in the PA test

2500 2000 1500 1000

500 0

page29image3651986688 page29image3651986976 page29image3651987952 page29image3651988160 page29image3651918688 page29image3651990064 page29image3651922432

Y o u n g

Y o u n g + M e t

Ag e d

Ag e d + M e t

Locomotor activity of Young, Young+Met, Aged, Aged+Met groups